Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ALNT
Deeply overvalued
ALLIENT INC
Price$109.91
Model IV$33.38
P/IV3.43
Premium +229%
Return to IV: -69.6%
Market implies +24.4%/yr
vs model +9.5% · above model
ALOY
Valuation N/A
REALLOYS INC.
Price$7.32
Model IV—
P/IV—
Market implies +76.7%/yr
vs model +0.0% · above model
ALRS
Deeply overvalued
ALERUS FINANCIAL CORP
Price$31.07
Model IV$14.09
P/IV2.28
Premium +121%
Return to IV: -54.7%
ALT
Valuation N/A
Altimmune, Inc.
Price$2.61
Model IV—
P/IV—
Market implies +140.0%/yr
ALTI
Deeply undervalued
AlTi Global, Inc.
Price$2.61
Model IV$5.93
P/IV0.52
Discount 56%
Return to IV: +127.3%
Market implies -13.9%/yr
vs model +35.5% · below model
ALVO
Deeply undervalued
Alvotech
Price$5.78
Model IV$13.26
P/IV0.46
Discount 56%
Return to IV: +129.4%
Market implies -14.1%/yr
vs model +50.0% · below model
ALX
Deeply overvalued
ALEXANDERS INC
Price$240.99
Model IV$181.27
P/IV1.37
Premium +33%
Return to IV: -24.8%
AMAL
Overvalued
Amalgamated Financial Corp.
Price$46.58
Model IV$37.56
P/IV1.26
Premium +24%
Return to IV: -19.4%
AMBQ
Valuation N/A
Ambiq Micro, Inc.
Price$58.56
Model IV—
P/IV—
Market implies +42.5%/yr
AMCX
Deeply undervalued
AMC Global Media Inc.
Price$10.81
Model IV$35.78
P/IV0.34
Discount 70%
Return to IV: +231.0%
Market implies -21.8%/yr
vs model +0.0% · below model
AMN
Deeply undervalued
AMN HEALTHCARE SERVICES INC
Price$36.52
Model IV$63.74
P/IV0.54
Discount 43%
Return to IV: +74.5%
Market implies -4.5%/yr
vs model +5.7% · below model
AMPH
Deeply undervalued
Amphastar Pharmaceuticals, Inc.
Price$26.62
Model IV$44.06
P/IV0.55
Discount 40%
Return to IV: +65.5%
Market implies +1.0%/yr
vs model +11.0% · below model
AMPL
Deeply overvalued
Amplitude, Inc.
Price$15.67
Model IV$5.85
P/IV2.25
Premium +168%
Return to IV: -62.7%
Market implies +12.8%/yr
vs model +19.7% · below model
AMPX
Deeply overvalued
Amprius Technologies, Inc.
Price$9.44
Model IV$2.13
P/IV4.47
Premium +343%
Return to IV: -77.4%
Market implies +29.7%/yr
vs model +50.0% · below model
AMRC
Overvalued
Ameresco, Inc.
Price$21.33
Model IV$18.29
P/IV1.32
Premium +17%
Return to IV: -14.2%
Market implies +8.4%/yr
vs model +8.5% · in line
AMSC
Deeply overvalued
AMERICAN SUPERCONDUCTOR CORP /DE/
Price$30.52
Model IV$8.76
P/IV3.57
Premium +248%
Return to IV: -71.3%
Market implies +24.4%/yr
vs model +28.9% · below model
AMSF
Fairly valued
AMERISAFE INC
Price$24.41
Model IV$22.12
P/IV1.11
Premium +10%
Return to IV: -9.4%
AMTB
Deeply overvalued
Amerant Bancorp Inc.
Price$28.77
Model IV$15.98
P/IV1.83
Premium +80%
Return to IV: -44.5%
AMWD
Valuation N/A
AMWD
Price$48.09
Model IV—
P/IV—
Limited data — see page
ANAB
Fairly valued
ANAPTYSBIO, INC
Price$45.95
Model IV$41.67
P/IV1.29
Premium +10%
Return to IV: -9.3%
Market implies -0.8%/yr
vs model +38.8% · below model
ANGO
Deeply overvalued
ANGIODYNAMICS INC
Price$11.52
Model IV$8.70
P/IV1.79
Premium +32%
Return to IV: -24.5%
Market implies +1.1%/yr
vs model +2.0% · in line
ANGX
Deeply overvalued
Angel Studios, Inc.
Price$3.98
Model IV$1.83
P/IV2.78
Premium +117%
Return to IV: -54.0%
Market implies +14.0%/yr
vs model +15.0% · in line
ANIP
Deeply undervalued
ANI PHARMACEUTICALS INC
Price$73.89
Model IV$198.38
P/IV0.37
Discount 63%
Return to IV: +168.5%
Market implies +0.9%/yr
vs model +20.1% · below model
ANL
Valuation N/A
Adlai Nortye Group Ltd.
Price$15.62
Model IV—
P/IV—
Market implies +78.4%/yr
ANNX
Valuation N/A
Annexon, Inc.
Price$4.02
Model IV—
P/IV—
Limited data — see page
ANRO
Valuation N/A
Alto Neuroscience, Inc.
Price$24.37
Model IV—
P/IV—
Limited data — see page
AOMD
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$24.73
Model IV—
P/IV—
Limited data — see page
AOMN
Valuation N/A
Angel Oak Mortgage REIT, Inc.
Price$24.87
Model IV—
P/IV—
Limited data — see page
AORT
Fairly valued
ARTIVION, INC.
Price$21.26
Model IV$19.00
P/IV1.20
Premium +12%
Return to IV: -10.6%
Market implies -3.0%/yr
vs model +10.2% · below model
AOSL
Valuation N/A
ALPHA & OMEGA SEMICONDUCTOR Ltd
Price$27.87
Model IV—
P/IV—
Market implies +84.1%/yr
APEI
Fairly valued
AMERICAN PUBLIC EDUCATION INC
Price$47.87
Model IV$43.55
P/IV0.94
Premium +10%
Return to IV: -9.0%
Market implies +6.0%/yr
vs model +7.0% · in line
API
Deeply overvalued
Agora, Inc.
Price$4.08
Model IV$2.98
P/IV1.48
Premium +37%
Return to IV: -27.1%
Market implies +9.3%/yr
vs model +7.1% · in line
APOG
Undervalued
APOGEE ENTERPRISES, INC.
Price$40.59
Model IV$55.75
P/IV0.72
Discount 27%
Return to IV: +37.4%
Market implies -1.4%/yr
vs model +4.7% · below model
APPS
Deeply overvalued
Digital Turbine, Inc.
Price$10.43
Model IV$3.04
P/IV3.83
Premium +243%
Return to IV: -70.8%
AQST
Valuation N/A
Aquestive Therapeutics, Inc.
Price$4.78
Model IV—
P/IV—
Market implies +38.8%/yr
ARCI
Valuation N/A
Archimedes Tech SPAC Partners III Co.
Price$10.05
Model IV—
P/IV—
Limited data — see page
ARCIU
Valuation N/A
Archimedes Tech SPAC Partners III Co.
Price$10.24
Model IV—
P/IV—
Limited data — see page
ARCO
Deeply undervalued
Arcos Dorados Holdings Inc.
Price$7.77
Model IV$33.94
P/IV0.21
Discount 77%
Return to IV: +336.8%
Market implies -27.4%/yr
vs model +15.2% · below model
ARCT
Deeply overvalued
Arcturus Therapeutics Holdings Inc.
Price$13.74
Model IV$9.83
P/IV1.44
Premium +40%
Return to IV: -28.5%
Market implies +9.2%/yr
vs model +50.0% · below model
ARDT
Deeply undervalued
Ardent Health, Inc.
Price$11.30
Model IV$24.45
P/IV0.45
Discount 54%
Return to IV: +116.4%
Market implies -4.1%/yr
vs model +9.2% · below model
ARDX
Deeply undervalued
ARDELYX, INC.
Price$3.28
Model IV$11.13
P/IV0.31
Discount 71%
Return to IV: +239.4%
Market implies -20.9%/yr
vs model +50.0% · below model
ARHS
Deeply overvalued
Arhaus, Inc.
Price$9.69
Model IV$5.99
P/IV1.28
Premium +62%
Return to IV: -38.2%
Market implies +16.3%/yr
vs model +12.7% · above model
ARI
Deeply undervalued
Apollo Commercial Real Estate Finance, Inc.
Price$6.24
Model IV$10.07
P/IV0.62
Discount 38%
Return to IV: +61.4%
ARKO
Valuation N/A
ARKO Corp.
Price$4.11
Model IV—
P/IV—
Market implies -6.0%/yr
vs model +3.7% · below model
ARLO
Valuation N/A
Arlo Technologies, Inc.
Price$12.40
Model IV—
P/IV—
Market implies +27.3%/yr
AROW
Overvalued
ARROW FINANCIAL CORP
Price$36.38
Model IV$28.10
P/IV1.33
Premium +29%
Return to IV: -22.8%
ARQQ
Valuation N/A
Arqit Quantum Inc.
Price$17.23
Model IV—
P/IV—
Market implies +106.6%/yr
ARRY
Fairly valued
Array Technologies, Inc.
Price$3.68
Model IV$4.19
P/IV0.96
Discount 12%
Return to IV: +14.0%
Market implies -2.2%/yr
vs model +1.7% · below model
ARTNA
Deeply overvalued
ARTESIAN RESOURCES CORP
Price$33.63
Model IV$21.84
P/IV1.52
Premium +54%
Return to IV: -35.1%
ARTV
Valuation N/A
Artiva Biotherapeutics, Inc.
Price$6.94
Model IV—
P/IV—
Market implies +93.8%/yr
ARVN
Deeply undervalued
ARVINAS, INC.
Price$7.64
Model IV$23.24
P/IV0.33
Discount 67%
Return to IV: +204.2%
Market implies -18.9%/yr
vs model +48.8% · below model
ASA
Valuation N/A
ASA Gold & Precious Metals Ltd
Price$56.36
Model IV—
P/IV—
Limited data — see page
ASAN
Fairly valued
Asana, Inc.
Price$10.07
Model IV$8.80
P/IV0.96
Premium +14%
Return to IV: -12.6%
Market implies +0.1%/yr
vs model +20.2% · below model
ASC
Fairly valued
Ardmore Shipping Corp
Price$19.28
Model IV$18.57
P/IV0.96
Premium +4%
Return to IV: -3.7%
Market implies +0.0%/yr
vs model +0.9% · in line
ASIC
Deeply overvalued
Ategrity Specialty Insurance Co Holdings
Price$25.93
Model IV$15.74
P/IV1.72
Premium +65%
Return to IV: -39.3%
ASIX
Fairly valued
AdvanSix Inc.
Price$16.24
Model IV$16.49
P/IV1.01
Discount 2%
Return to IV: +1.5%
Market implies +1.1%/yr
vs model +2.8% · in line
ASM
Valuation N/A
AVINO SILVER & GOLD MINES LTD
Price$5.55
Model IV—
P/IV—
Market implies +150.0%/yr
ASMB
Deeply undervalued
ASSEMBLY BIOSCIENCES, INC.
Price$23.53
Model IV$40.07
P/IV0.57
Discount 41%
Return to IV: +70.3%
Market implies -9.0%/yr
vs model +50.0% · below model
ASPI
Valuation N/A
ASP Isotopes Inc.
Price$2.65
Model IV—
P/IV—
Market implies +58.6%/yr
vs model +5.0% · above model
ASPN
Valuation N/A
ASPEN AEROGELS INC
Price$5.65
Model IV—
P/IV—
Market implies +68.2%/yr
vs model +6.0% · above model